We are excited to announce that SMSbiotech has been granted a new Japanese patent for our innovative stem cell technology:

‍

Japanese Patent No. 7,717,712 — “Stem Cell Compositions and Methods of Repairing Tissue”

‍

Granted on July 25, 2025

‍

This newly issued patent expands and strengthens SMSbiotech’s worldwide patent portfolio, further reinforcing our global leadership in regenerative medicine. It builds on our growing intellectual property foundation supporting the bio-manufacturing and therapeutic use of SMS cells for tissue repair and regeneration.

‍

This milestone underscores SMSbiotech’s continued progress toward democratizing the application of adult stem cell technologies for human health.